Biomaterial Degradation Analysis
Biomaterial Degradation Analysis - Related Videos
07:44
Overview of Biomaterials
0 Views •
2023
Biomaterials are materials engineered to interact favorably with biological organisms or molecules. These materials can be derived from or produced by an organism, or can even be a synthesized polymer. Engineers use these novel materials in a wide range of applications, such as tissue engineering, biosensing and drug delivery. This video introduces common biologically derived materials, and provides examples of common techniques used to process them. Key challenges in the field are discussed,...
07:58
Electrospinning of Silk Biomaterials
0 Views •
2023
Silk fibers have been processed and used to create fabrics and threads for centuries. However, the solubilizing of silk fibers, thereby turning it into a versatile pre-polymer solution is a much newer technology. Solubilized silk can be processed in many different ways to create a biocompatible material with controllable mechanical properties. This video introduces the processing of silk from silk worm cocoons, and shows how the silk solution can be used to create a fiber mat via...
11:19
Silk Film Culture System for in vitro Analysis and Biomaterial Design
0 Views •
Cited by 22 •
2012
Silk films are a novel class of biomaterials readily customizable for an array of biomedical applications. The presented silk film culture system is highly adaptable to a variety of in vitro analyses. This system represents a biomaterial design platform offering in vitro optimization before direct translation to in vivo models.
09:05
Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
0 Views •
Cited by 70 •
2016
Protein abundance reflects the rates of both protein synthesis and protein degradation. This article describes the use of cycloheximide chase followed by western blotting to analyze protein degradation in the model unicellular eukaryote, Saccharomyces cerevisiae (budding yeast).
13:37
Polymer Microarrays for High Throughput Discovery of Biomaterials
0 Views •
Cited by 32 •
2012
A description of the formation of a polymer microarray using an on-chip photopolymerization technique. The high throughput surface characterization using atomic force microscopy, water contact angle measurements, X-ray photoelectron spectroscopy and time of flight secondary ion mass spectrometry and a cell attachment assay is also described.
FAQs
Hydrolysis, enzymatic activity, oxidation, and physical erosion can produce different degradation patterns. The relevant pathway depends on the material and the biological or simulated physiological setting being evaluated. Comparing these mechanisms helps explain why breakdown may alter drug release, tissue interactions, or material performance over time, rather than treating degradation as a single uniform process.
Mass change, molecular structure, mechanical properties, and released byproducts provide complementary evidence of material breakdown. Tracking these variables over time shows whether degradation is associated with loss of structural performance, changes in composition, or release of substances that may affect biological responses. Together, the measurements connect physical changes with safety and therapeutic function.
Biological and simulated physiological conditions provide settings for evaluating how a material changes in environments relevant to its intended use. Examining degradation across these conditions can clarify how the surrounding context influences breakdown and its consequences. This comparison supports more informed material selection and helps researchers judge whether observed behavior is consistent with the planned application.
A typical evaluation begins by selecting the biological or simulated physiological condition, then monitoring the material over time. Researchers assess changes in mass, molecular structure, mechanical properties, and released byproducts. They interpret these measurements together to determine how breakdown relates to performance, drug release, tissue interactions, and possible toxicity in the intended cancer research application.
For biodegradable drug-delivery systems, degradation measurements help link material breakdown with controlled drug release. Researchers can use changes in mass, structure, and released byproducts to evaluate whether the material’s behavior supports the intended therapeutic function. This information assists material selection and contributes to more predictable cancer therapies by connecting degradation with delivery performance.
Released byproducts are tracked alongside changes in material mass, molecular structure, and mechanical properties. Their presence provides information about what enters the surrounding biological or simulated environment as the material breaks down. In cancer research, this evidence helps assess potential toxicity and tissue interactions, especially for implantable scaffolds, drug-delivery systems, and tumor models.